[10] [11] Based on data from retatrutide clinical trials (NEJM, 2023) and experience with similar approved agents, patients may experience: Redness, swelling, or itching at the injection site, which typically resolves within a few hours to days Bruising or mild pain immediately following injection Nodules or localised reactions beneath the skin, which may occur with repeated injections at the same site These reactions are generally mild and self-limiting
In recent years, GLP-1 RAs have emerged as potential therapeutic agents in HS
Research Evidence Studies specifically examining weight loss and erectile function show: Improvement rates: A significant proportion of men with obesity-related ED report improvement or resolution with substantial weight loss
How access to medical weight loss is improving in Virginia More providers are treating obesity as a chronic disease Virginias healthcare systems are increasingly recognizing obesity as a complex, long-term medical condition, one that requires more than just diet and exercise advice
We assess your different needs, and if appropriate, our medical team may recommend medications to support your weight loss journey